Overview
Watershed Informatics offers Watershed.bio, a subscription platform for analyzing multi-omics data used by researchers in academia, pharmaceutical companies, and biotech firms. The platform lets users process diverse biological data and generate publication-quality figures with minimal coding through a web-based interface that links biology and informatics. It differentiates itself by acting as an active partner, providing infrastructure and data science expertise along with services such as custom workflow development and consulting, not just software. Its goal is to let clients focus on discovery by handling data processing, analysis pipelines, and expert support in the background.
Work here?Claim your company
Simplify's take
What believers are saying
- Watershed closed a $14.5M Series A in 2025, extending runway.
- The company says customer demand drove ARR from $0 to $1M within twelve months.
- Watershed is hiring eight roles in November 2026, signaling product and sales expansion.
What critics are saying
- Elucidata and Matterworks attack the same multi-omics workflow market, compressing pricing power.
- Watershed serves hundreds, not thousands, so one pharma slowdown can stall ARR growth.
- If AI-native notebook tools bundle workflows, Watershed's managed-service moat disappears by 2027.
What makes Watershed Informatics unique
- Watershed bundles bioinformatics software, templates, and scientists into one workflow platform.
- The company claims 300TB monthly processing and 100-plus analysis templates on its platform.
- Case studies from Harvard, SalioGen, and Violet show adoption across coding skill levels.
Help us improve and share your feedback! Did you find this helpful?
Funding
Industry standards